<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:department>College of Medical, Veterinary &amp;Life Sci</gtr:department><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EEE5331C-7D11-4578-BAC5-788C990A6C47"><gtr:id>EEE5331C-7D11-4578-BAC5-788C990A6C47</gtr:id><gtr:firstName>Iain</gtr:firstName><gtr:surname>McInnes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A33FCDA7-0D04-488D-9605-CD0DEC7F966B"><gtr:id>A33FCDA7-0D04-488D-9605-CD0DEC7F966B</gtr:id><gtr:firstName>Margaret</gtr:firstName><gtr:otherNames>McCann</gtr:otherNames><gtr:surname>Harnett</gtr:surname><gtr:orcidId>0000-0001-5740-3028</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2D6F6946-D55B-43F7-A0F5-D4556B5B4D86"><gtr:id>2D6F6946-D55B-43F7-A0F5-D4556B5B4D86</gtr:id><gtr:firstName>Foo</gtr:firstName><gtr:otherNames>Yew</gtr:otherNames><gtr:surname>Liew</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3E91007A-C382-4933-9141-61911A5056ED"><gtr:id>3E91007A-C382-4933-9141-61911A5056ED</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Garside</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9EA5D7D6-5FA2-4952-A6A4-8B0F274CDBE1"><gtr:id>9EA5D7D6-5FA2-4952-A6A4-8B0F274CDBE1</gtr:id><gtr:firstName>Allan</gtr:firstName><gtr:otherNames>McI</gtr:otherNames><gtr:surname>Mowat</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G9901386"><gtr:id>FB9044CC-4EB9-4430-9350-648BF79D18AF</gtr:id><gtr:title>Dissection of the cellular and molecular basis of immunoregulation in vivo</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9901386</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-05-01</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2000-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>287404</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Infection, Immunity and Inflammation</gtr:department><gtr:description>T cell priming and tolerance</gtr:description><gtr:id>DDA05D51-9292-41FC-8E28-86F71FFADA7D</gtr:id><gtr:impact>This collaboration resulted in 4 publications prior to the 2006 reporting date and also MRC award G0500580</gtr:impact><gtr:partnerContribution>collaboration resulted in additional manuscripts pre 2006 and also in MRC award G0500580</gtr:partnerContribution><gtr:piContribution>Developed in situ analysis of the molecular and cellular events underpinning T cell priming and tolerance</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Strathclyde</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Strathclyde Institute of Pharmacy &amp; Biomedical Sciences</gtr:department><gtr:description>In situ analysis of immunomodulation by the filarial nematode product, ES-62</gtr:description><gtr:id>28FB3687-1EE7-4D3C-A9C5-885B579E80DC</gtr:id><gtr:impact>This longterm collaboration between the PI on this award and a PI at SIPBS has led to a considerable number of publications and grants (including MRC) over the years. By capitalising on the development of the instant transgenesis and laser scanning technologies developed in this current award, and building on our strong joint publications from other funding, we obtained Wellcome Trust Programme Grant, American Asthma Foundation and Arthritis Research UK funding to study the immunomodulatory properties of ES-62 in allergic and autoimmune inflammatory disease. In turn, this has allowed us in collaboration with other PIs at GU and SU, to obtain funding (ARUK and BBSRC) to study the impact of ES-62 on the microbiome (and consequently, musculoskeletal disease) and ageing.</gtr:impact><gtr:partnerContribution>Longterm collaboration with PI from SIPBS on the in vivo dissection of the immunomodulatory properties of the filarial nematode product, ES-62 and it's therapeutic potential in inflammatory disease - in this particular collaboration, this involved his group characterising the immunological parameters of ES-62 in vivo</gtr:partnerContribution><gtr:piContribution>we provided training in the relevant techniques for the analysis of tracking the functional responses of antigen-specific T cells that were modulated by exposure to the filarial nematode product, ES-62 and carried out the key laser scanning cytometry experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>open days</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BA0560D8-7967-454D-90C7-95CAD094DDBE</gtr:id><gtr:impact>Describing work to prospective undergraduate and postgraduate students

recruited Ph D students</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sympoium speaker</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D04A7198-8226-466D-B2CC-E324536658ED</gtr:id><gtr:impact>European Microscopy Congress Manchester September 2012

invited to present symposium talk about in situ tracking of immune responses to international audience and hence provide opportunities of further training/collaborations with peers</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open days/interviews</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>614BED03-3B06-417D-B067-DC6B669DD6A3</gtr:id><gtr:impact>1. Describing work to potential postgraduate students at open days and/or &amp;quot;research sessions&amp;quot; 2. interviewed by undergraduate students on science communication course in order that they could prepare a &amp;quot;newspaper&amp;quot;-type article

recruited a Ph D student</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Programme Grant (The filarial nematode immunomodulator ES-62 as a tool in novel drug development for mast cell-dependent inflammatory diseases)</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>39F75B9B-32A6-4487-AD70-0EBB54192151</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>148940</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Medical Research Scotland</gtr:description><gtr:end>2013-04-02</gtr:end><gtr:fundingOrg>Medical Research Scotland</gtr:fundingOrg><gtr:id>59322571-82F1-4F57-9B73-749D1E3D0254</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>276031</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC G0500580</gtr:description><gtr:end>2009-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>2023F12E-3D1D-4725-8384-603A5E972121</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>462126</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SPAR Programme Award</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>American Asthma Foundation</gtr:fundingOrg><gtr:id>CE1006E9-3742-40FB-B67A-C2FF5DDBAF5C</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Development of laser scanning cytometry has allowed in situ analysis of the cellular and molecular events underpinning development of the immune response in health and disease within the physiological tissue environment, rather than in a testtube.</gtr:description><gtr:id>7F571E38-A0B8-4A5B-B121-D39CE000951B</gtr:id><gtr:impact>This approach has greatly reduced the numbers of
animals required to study signalling in the immune
response and has also allowed validation of therapeutic targets identified in animal models in rare, clinically relevant patient tissue</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>in situ analysis</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have further developed our novel techniques of combining instant transgenesis using trackable retroviral and lentiviral vectors for dissecting the molecular mechanisms underlying B cell development in vitro and in vivo that can be analysed in situ at the single cell level within their physiological anatomical niche by laser scanning cytometry</gtr:description><gtr:id>A89DBEA1-D983-410D-99D9-BE53E23020D5</gtr:id><gtr:impact>these systems have only been optimised for B cell development since the RA started in July but are expected to have impact, in terms of publications, in 2010. This approach has greatly reduced the numbers of animals required to study signalling in the immune responses for 2 major reasons. 1. Traditionally, genetic modification has required transgenic or knockout procedures which require extensive crossbreeding onto the required genetic backgrounds whilst this instant transgenesis, allows analysis of wild type and modified cells within a single animal without any breeding. 2. Signalling assays have traditionally required large numbers of animals to prepare sufficient cells for biochemical analysis. Development of in situ laser scanning cytometry assays have the negated the need for large numbers of cells as this analysis allows investigation at the single cell level in individual animals. In addition, development of laser scanning cytometry assays allows such analysis within the physiological lymphoid tissue environment, rather than in a test-tube.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>In situ analysis of instant transgenesis systems</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/93B10EC8-8BFD-4C21-B9FF-39B0270673E6"><gtr:id>93B10EC8-8BFD-4C21-B9FF-39B0270673E6</gtr:id><gtr:title>Effect of activated antigen-specific B cells on ES-62-mediated modulation of effector function of heterologous antigen-specific T cells in vivo.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0b3604c9d14a82f4603da6f333899c25"><gtr:id>0b3604c9d14a82f4603da6f333899c25</gtr:id><gtr:otherNames>Marshall FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3BE4D5C6-BC14-4560-9A74-3A4C4A1CBF36"><gtr:id>3BE4D5C6-BC14-4560-9A74-3A4C4A1CBF36</gtr:id><gtr:title>ES-62, an immunomodulator secreted by filarial nematodes, suppresses clonal expansion and modifies effector function of heterologous antigen-specific T cells in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0b3604c9d14a82f4603da6f333899c25"><gtr:id>0b3604c9d14a82f4603da6f333899c25</gtr:id><gtr:otherNames>Marshall FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9DDF5784-F75E-442D-A523-A38698E52E61"><gtr:id>9DDF5784-F75E-442D-A523-A38698E52E61</gtr:id><gtr:title>Laser scanning cytometry: capturing the immune system in situ.</gtr:title><gtr:parentPublicationTitle>Methods in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b095ff8a06b88bf8702d45a324bb44b6"><gtr:id>b095ff8a06b88bf8702d45a324bb44b6</gtr:id><gtr:otherNames>McGrath MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0091-679X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C276AE11-5006-4C1D-8259-A47B5AC31551"><gtr:id>C276AE11-5006-4C1D-8259-A47B5AC31551</gtr:id><gtr:title>Direct quantitation of T cell signaling by laser scanning cytometry.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3eeb32a88afd91eeb50f659e7a5c5a77"><gtr:id>3eeb32a88afd91eeb50f659e7a5c5a77</gtr:id><gtr:otherNames>Grierson AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2F6EA887-72D7-4C33-A51F-01FD855DA38F"><gtr:id>2F6EA887-72D7-4C33-A51F-01FD855DA38F</gtr:id><gtr:title>Laser scanning cytometry: understanding the immune system in situ.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b3a08eb938c88d3811f9299633e1d3fc"><gtr:id>b3a08eb938c88d3811f9299633e1d3fc</gtr:id><gtr:otherNames>Harnett MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/950388FF-D33D-4021-9B00-339AA9BED1E4"><gtr:id>950388FF-D33D-4021-9B00-339AA9BED1E4</gtr:id><gtr:title>Inverse Rap1 and phospho-ERK expression discriminate the maintenance phase of tolerance and priming of antigen-specific CD4+ T cells in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e17a596de782db8c2cfd2a8cf261856a"><gtr:id>e17a596de782db8c2cfd2a8cf261856a</gtr:id><gtr:otherNames>Morton AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2CD2CDCF-0FE1-4DFB-A79F-F52B7A9B8B67"><gtr:id>2CD2CDCF-0FE1-4DFB-A79F-F52B7A9B8B67</gtr:id><gtr:title>Fluorescence-based assays as tools for understanding immunologic processes.</gtr:title><gtr:parentPublicationTitle>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e56fcf8d8d981a21ed12fb667f1ee915"><gtr:id>e56fcf8d8d981a21ed12fb667f1ee915</gtr:id><gtr:otherNames>Leonardo SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1081-1206</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/48F0A485-B14A-4263-9A39-CFC8346301FF"><gtr:id>48F0A485-B14A-4263-9A39-CFC8346301FF</gtr:id><gtr:title>Differences in the kinetics, amplitude, and localization of ERK activation in anergy and priming revealed at the level of individual primary T cells by laser scanning cytometry.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cce000290f55172411f291619c80b68e"><gtr:id>cce000290f55172411f291619c80b68e</gtr:id><gtr:otherNames>Adams CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9901386</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>